We are live on ! Find out more
VFA

Values First Advisors Portfolio holdings

AUM $192M
1-Year Est. Return 24.96%
This Fund
S&P 500
This Quarter Est. Return
+2.57%
1 Year Est. Return
+24.96%
3 Year Est. Return
+70.52%
5 Year Est. Return
+87.3%
10 Year Est. Return
AUM
$182M
AUM Growth
-$2.71M
Cap. Flow
+$874K
Cap. Flow %
0.48%
Top 10 Hldgs %
29.39%
Holding
305
New
32
Increased
91
Reduced
92
Closed
81

Sector Composition

Rank Sector Weight
1 Healthcare 15.62%
2 Technology 14.47%
3 Industrials 10.33%
4 Consumer Discretionary 6.72%
5 Real Estate 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCKT icon
276
Rocket Pharmaceuticals
RCKT
$348M
-5,840
Closed -$108K
RGEN icon
277
Repligen
RGEN
$7.44B
-420
Closed -$62.5K
RLAY icon
278
Relay Therapeutics
RLAY
$4.02B
-10,579
Closed -$74.9K
RLI icon
279
RLI Corp
RLI
$5.68B
-902
Closed -$69.8K
RNAM
280
DELISTED
Avidity Biosciences
RNAM
-688
Closed -$31.6K
ROBT icon
281
First Trust Nasdaq Artificial Intelligence and Robotics ETF
ROBT
$693M
-986
Closed -$43.2K
RVMD icon
282
Revolution Medicines
RVMD
$40.2B
-2,043
Closed -$92.7K
SKYY icon
283
First Trust Cloud Computing ETF
SKYY
$2.74B
-477
Closed -$48.8K
SLN
284
Silence Therapeutics
SLN
$521M
-3,091
Closed -$56.2K
SLV icon
285
iShares Silver Trust
SLV
$28.1B
-2,154
Closed -$61.2K
SNDX icon
286
Syndax Pharmaceuticals
SNDX
$1.84B
-1,546
Closed -$29.8K
SNPS icon
287
Synopsys
SNPS
$71.5B
-370
Closed -$187K
SNSR icon
288
Global X Internet of Things ETF
SNSR
$214M
-1,302
Closed -$45.2K
SRPT icon
289
Sarepta Therapeutics
SRPT
$1.66B
-471
Closed -$58.8K
STE icon
290
Steris
STE
$20.9B
-902
Closed -$219K
SYY icon
291
Sysco
SYY
$39.7B
-682
Closed -$53.2K
TGTX icon
292
TG Therapeutics
TGTX
$8.58B
-2,496
Closed -$58.4K
UTHR icon
293
United Therapeutics
UTHR
$26.3B
-251
Closed -$89.9K
VCYT icon
294
Veracyte
VCYT
$4.52B
-2,673
Closed -$91K
VKTX icon
295
Viking Therapeutics
VKTX
$4.04B
-884
Closed -$56K
VOO icon
296
Vanguard S&P 500 ETF
VOO
$968B
-1
Closed -$528
VRSK icon
297
Verisk Analytics
VRSK
$26.4B
-508
Closed -$136K
QTTB icon
298
Q32 Bio
QTTB
$450M
-741
Closed -$33K
RAPP
299
Rapport Therapeutics
RAPP
$1.95B
-1,507
Closed -$30.9K
NARI
300
DELISTED
Inari Medical, Inc. Common Stock
NARI
-3,116
Closed -$128K

Similar funds

Values First Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Values First Advisors held 305 positions worth $182M, down 1.5% from $184M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Values First Advisors's Q4 2024 filing shows 32 new, 91 increased, 92 reduced and 81 closed positions. Its largest new stake was GE Vernova: 1,949 shares worth $641K. The largest sale was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, an estimated $1.73M.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, down from 19% a quarter earlier, followed by Technology and Industrials.

  • Values First Advisors's largest Q4 2024 buy was GE Vernova: 1,949 shares worth $641K.
  • Values First Advisors added most to iShares 1-3 Year Treasury Bond ETF in Q4 2024, an estimated $2.31M increase.
  • Values First Advisors's biggest Q4 2024 reduction was PIMCO Enhanced Short Maturity Active Exchange-Traded Fund, cutting an estimated $1.73M.
  • Values First Advisors fully exited Idexx Laboratories in Q4 2024, selling an estimated $1.17M.
  • Values First Advisors's ten largest holdings make up 29% of its $182M portfolio in Q4 2024.
  • Values First Advisors opened 32 new positions and closed 81 in Q4 2024.
  • Values First Advisors's portfolio value fell 1.5% quarter-over-quarter to $182M.

Based on Values First Advisors's 13F filing for Q4 2024, filed 29 Jan 2025.